We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
+16.38%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
–
AUM
$71M
AUM Growth
+$26.4M
Cap. Flow
+$24M
Cap. Flow %
33.85%
Top 10 Hldgs %
86.77%
Holding
60
New
18
Increased
1
Reduced
6
Closed
24

Top Buys

Rank Stock Value
1
ABEO icon
Abeona Therapeutics
ABEO
+$14.8M
2
AMRS
Amyris Inc.
AMRS
+$7.71M
3
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
+$6.36M
4
REPL icon
Replimune Group
REPL
+$5.92M
5
HEXO
HEXO Corp. Common Shares
HEXO
+$5.48M

Top Sells

Rank Stock Value
1
CARM
Carisma Therapeutics
CARM
+$5.54M
2
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$2.59M
3
VUZI icon
Vuzix
VUZI
+$1.52M
4
EMWP
Eros Media World PLC
EMWP
+$1.5M
5
CRMD icon
CorMedix
CRMD
+$1.46M

Sector Composition

Rank Sector Weight
1 Healthcare 66.73%
2 Materials 11.48%
3 Industrials 0.19%
4 Consumer Staples 0.16%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGLBW
26
DELISTED
Sigma Labs, Inc. Warrant
SGLBW
$23K 0.03%
48,100
-151,736
-76% -$74.6K
ARTLW
27
DELISTED
Artelo Biosciences, Inc. Warrant
ARTLW
$19K 0.03%
65,000
– –
CHEKZ
28
DELISTED
Check-Cap Ltd. Series C Warrant
CHEKZ
$16K 0.02%
136,364
– –
MDGSW
29
DELISTED
Medigus Ltd. Series C Warrant
MDGSW
$6K 0.01%
63,286
– –
AMRHW
30
DELISTED
Ameri Holdings, Inc. Warrant
AMRHW
$4K 0.01%
98,700
-800
-0.8% -$44
BNTCW
31
DELISTED
Benitec Biopharma Limited
BNTCW
$4K 0.01%
50,000
– –
CREXW
32
DELISTED
Creative Realities, Inc. Warrant
CREXW
$1K ﹤0.01%
15,000
– –
PSTVZ
33
DELISTED
PLUS THERAPEUTICS, Inc. Series S Warrant
PSTVZ
$1K ﹤0.01%
259,200
– –
AIHS icon
34
Senmiao Technology Ltd
AIHS
$20.1M
– –
-4,036
Closed -$150K
ARCT icon
35
Arcturus Therapeutics
ARCT
$165M
– –
-22,081
Closed -$227K
BTAI icon
36
BioXcel Therapeutics
BTAI
$24.8M
– –
-9,937
Closed -$1.12M
CARM
37
DELISTED
Carisma Therapeutics
CARM
– –
-236,899
Closed -$5.54M
CRMD icon
38
CorMedix
CRMD
$564M
– –
-229,465
Closed -$1.46M
OCGN icon
39
Ocugen
OCGN
$403M
– –
-368,315
Closed -$1.06M
OPRA
40
Opera Ltd
OPRA
$1.68B
– –
-21,109
Closed -$212K
PHIO icon
41
Phio Pharmaceuticals
PHIO
$11.4M
– –
-16
Closed -$26K
PSTV icon
42
Plus Therapeutics
PSTV
$25M
– –
-104
Closed -$134K
TCOM icon
43
Trip.com Group
TCOM
$29B
– –
-21,308
Closed -$624K
VUZI icon
44
Vuzix
VUZI
$178M
– –
-667,565
Closed -$1.52M
HURA
45
TuHURA Biosciences
HURA
$130M
– –
-108
Closed -$104K
SEEL
46
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
– –
-15
Closed -$54K
DMK
47
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
– –
-12,620
Closed -$622K
BLCM
48
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
– –
-16,874
Closed -$177K
TPTX
49
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
– –
-68,841
Closed -$2.59M
EMWP
50
DELISTED
Eros Media World PLC
EMWP
– –
-39,169
Closed -$1.5M
1
2
3

Similar funds

EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
YSP
Yarra Square Partners New York $111M AUM 41.61% 1-Year Est. Return
GIM
Greenwich Investment Management Norwalk, Connecticut $109M AUM 9.72% 1-Year Est. Return
FWM
FMFE Wealth Management Syracuse, New York $108M AUM
CPG
Custom Portfolio Group Englewood, Colorado $127M AUM
WCM
Windham Capital Management Boston, Massachusetts $128M AUM 12.44% 1-Year Est. Return
ETIA
Epic Trust Investment Advisors Richland, Washington $90.8M AUM 22.03% 1-Year Est. Return
RCM
Rain Capital Management Lake Oswego, Oregon $142M AUM 15.53% 1-Year Est. Return

CVI Holdings's Q4 2019 Portfolio in Review

As of Q4 2019, CVI Holdings held 60 positions worth $71M, up 59% from $44.5M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

CVI Holdings deployed $24M of net new capital in Q4 2019, opening 18 new positions and adding to 1 existing holding. Its largest new stake was Abeona Therapeutics: 209,095 shares worth $17.1M.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, up from 39% a quarter earlier, followed by Materials and Industrials.

On the sell side, the largest reduction was Notable Labs, Ltd. Ordinary Shares, an estimated $193K trimmed.

  • CVI Holdings's largest Q4 2019 buy was Abeona Therapeutics: 209,095 shares worth $17.1M.
  • CVI Holdings added most to Farmmi Inc in Q4 2019, an estimated $92.5K increase.
  • CVI Holdings's biggest Q4 2019 reduction was Notable Labs, Ltd. Ordinary Shares, cutting an estimated $193K.
  • CVI Holdings fully exited Carisma Therapeutics in Q4 2019, selling an estimated $5.54M.
  • CVI Holdings's ten largest holdings make up 87% of its $71M portfolio in Q4 2019.
  • CVI Holdings opened 18 new positions and closed 24 in Q4 2019.
  • CVI Holdings's portfolio value rose 59% quarter-over-quarter to $71M.

Based on CVI Holdings's 13F filing for Q4 2019, filed 14 Feb 2020.